SaifM. U.S. Food and Drug Administration Approves Paclitaxel Protein-Bound Particles (Abraxane®) in Combination With Gemcitabine As First-Line Treatment of Patients With Metastatic Pancreatic Cancer. JOP 2013, 14, 686-688.